AU2015258807B2 - Systems and methods of managing treatment of a chronic condition by symptom tracking - Google Patents

Systems and methods of managing treatment of a chronic condition by symptom tracking Download PDF

Info

Publication number
AU2015258807B2
AU2015258807B2 AU2015258807A AU2015258807A AU2015258807B2 AU 2015258807 B2 AU2015258807 B2 AU 2015258807B2 AU 2015258807 A AU2015258807 A AU 2015258807A AU 2015258807 A AU2015258807 A AU 2015258807A AU 2015258807 B2 AU2015258807 B2 AU 2015258807B2
Authority
AU
Australia
Prior art keywords
patient
facial
symptoms
treatment
images
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015258807A
Other languages
English (en)
Other versions
AU2015258807A1 (en
Inventor
Steven Lo
John Lyons
David PENAKE
Lisa SAGINIAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corcept Therapeutics Inc
Original Assignee
Corcept Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corcept Therapeutics Inc filed Critical Corcept Therapeutics Inc
Publication of AU2015258807A1 publication Critical patent/AU2015258807A1/en
Application granted granted Critical
Publication of AU2015258807B2 publication Critical patent/AU2015258807B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1079—Measuring physical dimensions, e.g. size of the entire body or parts thereof using optical or photographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/60—Analysis of geometric attributes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
    • G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
    • G06V40/16—Human faces, e.g. facial parts, sketches or expressions
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Theoretical Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ecology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Multimedia (AREA)
  • Human Computer Interaction (AREA)
  • Geometry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AU2015258807A 2014-05-16 2015-05-18 Systems and methods of managing treatment of a chronic condition by symptom tracking Ceased AU2015258807B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461994815P 2014-05-16 2014-05-16
US61/994,815 2014-05-16
PCT/US2015/031408 WO2015176062A2 (en) 2014-05-16 2015-05-18 Systems and methods of managing treatment of a chronic condition by symptom tracking

Publications (2)

Publication Number Publication Date
AU2015258807A1 AU2015258807A1 (en) 2016-11-24
AU2015258807B2 true AU2015258807B2 (en) 2018-11-29

Family

ID=54480946

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015258807A Ceased AU2015258807B2 (en) 2014-05-16 2015-05-18 Systems and methods of managing treatment of a chronic condition by symptom tracking

Country Status (8)

Country Link
US (2) US9977875B2 (enExample)
EP (1) EP3143494B1 (enExample)
JP (2) JP6712233B2 (enExample)
CN (1) CN106662992A (enExample)
AU (1) AU2015258807B2 (enExample)
CA (1) CA2948575C (enExample)
ES (1) ES2871089T3 (enExample)
WO (1) WO2015176062A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2871089T3 (es) 2014-05-16 2021-10-28 Corcept Therapeutics Inc Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas
US11045134B2 (en) * 2016-01-19 2021-06-29 Washington University Depression brain computer interface for the quantitative assessment of mood state and for biofeedback for mood alteration
US12470894B2 (en) 2016-12-15 2025-11-11 Conquer Your Addiction Llc Systems and methods for proactively preempting/mitigating anxiety-related behaviors and associated issues/events
US11412353B2 (en) 2016-12-15 2022-08-09 Conquer Your Addiction Llc Systems and methods for monitoring for and preempting the risk of a future occurrence of a quarantine violation
US12342240B2 (en) 2016-12-15 2025-06-24 Conquer Your Addiction Llc Systems and methods for monitoring for and lowering the risk of addiction-related or restriction violation-related behavior(s)
US10497242B2 (en) 2016-12-15 2019-12-03 David H. Williams Systems and methods for monitoring for and preempting pre-identified restriction violation-related behavior(s) of persons under restriction
US10853897B2 (en) 2016-12-15 2020-12-01 David H. Williams Systems and methods for developing, monitoring, and enforcing agreements, understandings, and/or contracts
WO2018112048A1 (en) 2016-12-15 2018-06-21 Williams David H Systems and methods for providing location-based security and/or privacy for restricting user access
US11636941B2 (en) 2016-12-15 2023-04-25 Conquer Your Addiction Llc Dynamic and adaptive systems and methods for rewarding and/or disincentivizing behaviors
US12096308B2 (en) 2016-12-15 2024-09-17 Conquer Your Addiction Llc Systems and methods for conducting/defending digital warfare or conflict
JP2021520982A (ja) * 2018-02-19 2021-08-26 ジェイソン ハリソン，ハワード 医療診断用の画像収集および寸法分析のための方法及びシステム
JP7230409B2 (ja) * 2018-10-02 2023-03-01 カシオ計算機株式会社 判定装置、判定方法及び判定プログラム
US11728031B2 (en) 2018-10-12 2023-08-15 Bfc Med Llc Software application for patient care and related device, system, and method
CN110473629A (zh) * 2019-08-22 2019-11-19 南京航空航天大学 一种肾透析治疗方案推荐方法及系统
JP7419720B2 (ja) * 2019-09-24 2024-01-23 カシオ計算機株式会社 画像処理装置、画像処理方法及び画像処理プログラム
CN111493585A (zh) * 2020-04-24 2020-08-07 王晨庄 基于5g智能化的多用途综合远控床医疗体和智能方法
US11504048B2 (en) 2020-06-10 2022-11-22 Medtronic Monitoring, Inc. Triggering arrhythmia episodes for heart failure and chronotropic incompetence diagnosis and monitoring
CN116018652A (zh) * 2020-08-14 2023-04-25 赛诺菲 监测系统
CN112489746B (zh) * 2020-12-08 2024-07-05 深圳平安智慧医健科技有限公司 数据管理的任务推送方法、装置、电子设备及存储介质
KR102510347B1 (ko) * 2021-02-10 2023-03-20 고려대학교 산학협력단 위암 수술 이후 제2형 당뇨병 예후의 예측 방법
US12009103B1 (en) * 2021-03-04 2024-06-11 Edward R Silansky Systems, devices, and/or methods for managing health
JP7135146B1 (ja) 2021-03-26 2022-09-12 エヌ・ティ・ティ・コミュニケーションズ株式会社 投薬対象者管理システム、管理方法、管理制御装置、端末装置およびプログラム
WO2023027853A1 (en) * 2021-08-26 2023-03-02 Hypatia Group, Inc. Health monitoring system with precision eye-blocking filter
US20230381527A1 (en) * 2022-05-31 2023-11-30 West Affum Holdings Dublin DAC Wearable medical system with device parameters and patient information programmable via browser interface
CN117809857B (zh) * 2024-02-29 2024-06-07 广州市品众电子科技有限公司 一种基于人工智能的vr设备运行数据分析方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060036619A1 (en) * 2004-08-09 2006-02-16 Oren Fuerst Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs
US20100169409A1 (en) * 2008-08-04 2010-07-01 Fallon Joan M Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of parkinsons disease, movement and neurological disorders, and chronic pain
US20110224179A1 (en) * 2008-11-07 2011-09-15 John Newell-Price Medicament and method of diagnosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008210399A (ja) * 1997-03-14 2008-09-11 First Opinion Corp 疾患管理システム
JP2004065822A (ja) 2002-08-09 2004-03-04 Nippon Colin Co Ltd 遠隔診断システム
US20050283385A1 (en) * 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
US20080242977A1 (en) 2007-03-30 2008-10-02 General Electric Company Systems, methods and apparatus for longitudinal/temporal analysis of plaque lesions
JP6367557B2 (ja) * 2011-01-07 2018-08-01 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 臨床データ解析モジュールへの統合的なアクセスおよび臨床データ解析モジュールとの相互作用
CN102063579A (zh) * 2011-01-30 2011-05-18 潘亚萍 牙周电子病历系统及其操作方法
CN102231172A (zh) * 2011-06-10 2011-11-02 王坦 一种远程医疗信息采集系统
US20130006793A1 (en) 2011-06-29 2013-01-03 International Business Machines Corporation Migrating Computing Environment Entitlement Contracts Based on Seller and Buyer Specified Criteria
US10500216B2 (en) 2011-11-18 2019-12-10 Corcept Therapeutics, Inc. Optimizing mifepristone absorption
US9836581B2 (en) * 2012-08-16 2017-12-05 Ginger.io, Inc. Method for modeling behavior and health changes
CN103324853A (zh) * 2013-06-25 2013-09-25 上海交通大学 基于医学图像特征的相似度计算系统及方法
AU2014321267A1 (en) 2013-09-20 2016-05-05 Corcept Therapeutics, Inc. Systems and methods of treatment using intervention and tasking determination
CN103690149B (zh) * 2013-12-30 2016-08-17 惠州Tcl移动通信有限公司 通过面部拍照识别身体健康状况的移动终端及其实现方法
ES2871089T3 (es) 2014-05-16 2021-10-28 Corcept Therapeutics Inc Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060036619A1 (en) * 2004-08-09 2006-02-16 Oren Fuerst Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs
US20100169409A1 (en) * 2008-08-04 2010-07-01 Fallon Joan M Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of parkinsons disease, movement and neurological disorders, and chronic pain
US20110224179A1 (en) * 2008-11-07 2011-09-15 John Newell-Price Medicament and method of diagnosis

Also Published As

Publication number Publication date
US20150332020A1 (en) 2015-11-19
JP6712233B2 (ja) 2020-06-17
CN106662992A (zh) 2017-05-10
AU2015258807A1 (en) 2016-11-24
JP2020023573A (ja) 2020-02-13
EP3143494B1 (en) 2021-03-31
CA2948575C (en) 2023-08-08
ES2871089T3 (es) 2021-10-28
WO2015176062A2 (en) 2015-11-19
US11610666B2 (en) 2023-03-21
EP3143494A2 (en) 2017-03-22
US9977875B2 (en) 2018-05-22
WO2015176062A3 (en) 2015-12-30
EP3143494A4 (en) 2018-01-24
CA2948575A1 (en) 2015-11-19
US20180240544A1 (en) 2018-08-23
JP2017518283A (ja) 2017-07-06

Similar Documents

Publication Publication Date Title
US11610666B2 (en) Systems and methods of managing treatment of a chronic condition by symptom tracking
Khandelwal et al. Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions
Farmer et al. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: a retrospective cohort analysis in a large primary care database
Harbaugh et al. Association between long-term opioid use in family members and persistent opioid use after surgery among adolescents and young adults
Friedberg et al. Effects of a medical home and shared savings intervention on quality and utilization of care
Friedberg et al. Association between participation in a multipayer medical home intervention and changes in quality, utilization, and costs of care
JP6495300B2 (ja) 介入およびタスク決定を使用する処置のシステムおよび方法
Squires et al. Health care spending on diabetes in the US, 1996–2013
Giummarra et al. Polypharmacy and chronic pain: harm exposure is not all about the opioids
Pignon et al. Meta-analyses of randomised clinical trials in oncology
US10424400B2 (en) Clinical trial investigators performance assessment
US20130110551A1 (en) Systems and methods for managing chronic conditions
Ndumele et al. Association of state access standards with accessibility to specialists for Medicaid managed care enrollees
US20140229191A1 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
US20200315528A1 (en) System and method for monitoring and identifying posology efficacy for an an individual
Axeen et al. Association of daily doses of buprenorphine with urgent health care utilization
Hancock et al. Characterisation of the Australian adult population living with Asthma: severe-exacerbation frequency, long-term OCS use and adverse effects
Hall et al. Development and content validation of pruritus and symptoms assessment for atopic dermatitis (PSAAD) in adolescents and adults with moderate-to-severe AD
Vagge et al. A pilot study using electronic reminders for amblyopia treatment
Genberg et al. Impact of a digital web-based asthma platform, a real-life study
El Hajj et al. Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial
Derbes et al. Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients
HK1235498B (en) Systems and methods of managing treatment of cushing's disease by symptom tracking
Yousif et al. Development of a graphical tool to measure medication adherence in asthma patients: A mixed-methods pilot study
Philpot et al. A before and after analysis of health care utilization by patients enrolled in opioid controlled substance agreements for chronic noncancer pain

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired